PALOPOLI ed altri: Disciplina dei prodotti farmaceutici e della sperimentazione clinica sull'uomo

This procedure concerns the regulation of pharmaceutical products and clinical trials involving humans. It aims to ensure the safety, efficacy, and quality of medicines available to the public and to establish clear rules for conducting medical research. The regulation affects pharmaceutical companies, healthcare providers, researchers, and patients. It will introduce new standards for drug approval, clinical trial procedures, and post-market surveillance, impacting the development and availability of new treatments.